Starton Therapeutics Inc. — Form D
Starton Therapeutics Inc. of PARAMUS, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-22. The offering totals $2.1M, of which $2.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-10-22
- Form: D
- Accession: 0001743192-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.1M
- Amount sold: $2.1M
- Investors: 16
- Date of first sale: 2024-10-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-527514
Issuer
- Name: Starton Therapeutics Inc.
- CIK: 0001743192
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Incorporated: 2017
- Address: 215 COLLEGE ROAD, SUITE #300, PARAMUS, NJ, 07652
- Phone: 800-449-5405
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Kenneth Anderson | Director | Wellesley, MA |
| Eric Baum | Director | Charlotte, NC |
| Asher Chanan-Khan | Director | Jacksonville, FL |
| Moses Dodo | Director | Coral Gables, FL |
| Mohamad Hussein | Director | Melbourne Beach, FL |
| Nitin Kaushal | Director | Kelowna, A1 |
| Pedro Lichtinger Waisman | Director | Sunny Isles Beach, FL |
| Fotios Plakogiannis | Director | Whitestone, NY |
| Roy Waldron | Director | Fort Lauderdale, FL |
| Scott Kahn | Executive Officer | Paramus, NJ |
| Pedro Lichtinger Waisman | Executive Officer | Sunny Isles Beach, FL |
| Jamie Oliver | Executive Officer | Raleigh, NC |
| Cidnee Vaykovich | Director | New York, NY |
| Cidnee Vaykovich | Executive Officer | New York, NY |
| Keith Darragh | Executive Officer | Paramus, NJ |
| Pedro Waisman | Director | Paramus, NJ |
| Pedro Waisman | Executive Officer | Paramus, NJ |
| PEDRO LICHTINGER | Director | PARAMUS, NJ |
| PEDRO LICHTINGER | Executive Officer | PARAMUS, NJ |
| LITSA PERPERIDIS | Promoter | PARAMUS, NJ |
| ROY WALDON | Director | FORT LAUDERDALE, FL |
| ROMAN ROGOL | Director | NEW YORK, NY |
| Nintin Kaushal | Director | New York, NY |
Other filings by this issuer (8)
More